Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
4
4 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- AzetukalnerXEN1101Phase 39 trials
Xenon Pharmaceuticals Inc. · Focal Onset Seizures, Major Depressive Disorder, Bipolar Disorder
- RAP-219Phase 35 trials
Rapport Therapeutics Inc. · Focal Epilepsy, Epilepsy, Focal Seizure
- Staccato alprazolamUCB7538Phase 32 trials
UCB · Stereotypical Prolonged Seizures
- SPN-817BIS-001ER, Huperzine APhase 24 trials
Supernus Pharmaceuticals, Inc. · Focal Onset Seizures, Focal Impaired Awareness Seizures, Epilepsy
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.